Rifalazil

未知生产厂商

Rifalazil is a derivative of the antibiotic rifamycin. It is being investigated by ActivBiotics for the treatment of various bacterial infections.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Rifalazil is a derivative of the antibiotic rifamycin. It is being investigated by ActivBiotics for the treatment of various bacterial infections.

The potent antimycobacterial activity of rifalazil is due to inhibition of bacterial RNA polymerase.

Investigated for use/treatment in atherosclerosis, bacterial infection, and peripheral vascular disease.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
US 7772228 B2申请人: KANEKA CORP优先权: 2001
US
3 件公开
Low dose rifalazil compositions
US 8097607 B2申请人: CABANA BERNARD E优先权: 2003
US
3 件公开
Pharmaceutical compositions and uses thereof
US 2007248668 A1申请人: MICHAELIS ARTHUR F优先权: 2006
CN
US
2 件公开
USE OF RIFALAZIL TO TREAT COLONIC DISORDERS
US 2011117154 A1申请人: ACTIVBIOTICS PHARMA LLC优先权: 2009
CN
US
2 件公开
Intravenous rifalazil formulation and methods of use thereof
US 2004034021 A1申请人: MICHAELIS ARTHUR F优先权: 2003
US
Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US 2004106590 A1申请人: EISENSTEIN BARRY优先权: 2003
US
Rifalazil formulations
US 2005123602 A1申请人: MICHAELIS ARTHUR F优先权: 2004
US
ORAL ADMINISTRATION FORMS FOR CONTROLLED RELEASE OF RIFAMPICIN FOR THE TREATMENT OF BACTERIAL INFECTIONS AND INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
US 2013115286 A1申请人: BRUFANI MARIO优先权: 2010
US
COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM
CN 110944636 A申请人: BORODY THOMAS J优先权: 2017
CN
Compositions, devices and methods for treating obsessive-compulsive disorder
CN 110290790 A申请人: CENTRE FOR DIGESTIVE DISEASES优先权: 2017
CN